Cancer

Items 1-10 of 123

Page
per page
Set Descending Direction
  1. Adiponectin (human) ELISA Kit
    AG-45A-0001Y
    AG-45A-0001YEK-KI0196 wells
    CHF 430.00
    AG-45A-0001YTP-KI012 x 96 wells
    CHF 750.00
    Standardcurve
  2. Adiponectin (rat) ELISA Kit
    AG-45B-0026
    AG-45B-0026-KI0196 wellsINQ
    Adiponectin (rat) ELISA Kit
  3. Angiopoietin-2 (mouse) (rec.)
    AG-40B-0131
    AG-40B-0131-C01010 µg
    CHF 190.00
    AG-40B-0131-30103 x 10 µg
    CHF 380.00
  4. ANGPTL3 (fibrinogen-like domain) (human) (rec.)
    AG-40A-0071Y
    AG-40A-0071Y-C01010 µgINQ
    AG-40A-0071Y-C05050 µgINQ
    Replaces Prod. No. AG-40A-0071
  5. ANGPTL3 (human) ELISA Kit
    AG-45A-0014Y
    AG-45A-0014YEK-KI0196 wells
    CHF 540.00
    ANGPTL3 (human) ELISA Kit
  6. ANGPTL4 (fibrinogen-like domain) (human) (rec.)
    AG-40A-0070
    AG-40A-0070-C01010 µg
    CHF 240.00
    AG-40A-0070-C05050 µg
    CHF 720.00
  7. ANGPTL6 (human) ELISA Kit
    AG-45A-0016Y
    AG-45A-0016YEK-KI0196 wells
    CHF 570.00
    ANGPTL6 (human) ELISA Kit
  8. anti-Angiopoietin-2 (human), mAb (rec.) (blocking) (Angy-1-4) (preservative free)
    AG-27B-0015PF
    AG-27B-0015PF-C100100 µg
    CHF 350.00
    AG-27B-0015PF-C500500 µg
    CHF 950.00
    AG-27B-0015PF-M0011 mg
    CHF 1'700.00
    Structure of the recombinant antibody anti-Angiopoietin-2 (human), mAb (rec.) (blocking) (Angy-1-4) (preservative free) (Prod. No. AG-27B-0015PF). The single chain variable human fragment (ScFv) selected by antibody phage display technology and specific t
  9. anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1)
    AG-27B-0016
    AG-27B-0016-C100100 µg
    CHF 350.00
    Structure of the recombinant antibody anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (Prod. No. AG-27B-0016). The single chain variable human fragment (ScFv) selected by antibody phage display technology and specific to the antigen of interest is f

Items 1-10 of 123

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.